Development and validation of a machine learning model for critical progression risk in pediatric severe

Xiaoqian Ma1, Wu Zhao2, Qi Sun1

  • 1Department of Pediatrics, The First Affiliated Hospital of Bengbu Medical University, Bengbu, Anhui, China.

Scientific Reports
|December 2, 2025
PubMed

Insights

Machine learning accurately predicts severe community-acquired pneumonia (SCAP) progression in children to critical SCAP (cSCAP). Key predictors include procalcitonin and lactate dehydrogenase, aiding early risk stratification.

Area of Science:

  • Pediatric critical care medicine
  • Machine learning applications in healthcare
  • Predictive modeling for infectious diseases

Background:

  • Severe community-acquired pneumonia (SCAP) poses a significant risk of progression to critical SCAP (cSCAP) in children.
  • Early identification of children at high risk for cSCAP is crucial for timely intervention and improved outcomes.
  • Existing predictive tools may lack the accuracy and specificity required for effective clinical decision-making.

Purpose of the Study:

  • To develop and validate a machine learning-based predictive model for the progression of SCAP to cSCAP in pediatric patients.
  • To identify key clinical variables that are most predictive of cSCAP development.
  • To enhance early risk stratification and clinical decision support for managing pediatric SCAP.

Main Methods:

  • Retrospective analysis of clinical data from 211 pediatric SCAP patients.
  • Utilized Logistic Regression (LR) and LASSO for variable selection.
  • Developed and compared seven machine learning models (LR, DT, RF, XGBoost, NB, KNN, SVM) for prediction.
  • Employed SHAP analysis for model interpretability.

Main Results:

  • The Extreme Gradient Boosting (XGBoost) model demonstrated superior performance with an AUC of 0.98.
  • Key predictors identified include procalcitonin (PCT), lactate dehydrogenase (LDH), Red Cell Distribution Width-Coefficient of Variation (RDW-CV), and blood urea nitrogen (BUN).
  • The XGBoost model achieved high accuracy (0.89), sensitivity (0.98), and specificity (0.75).

Conclusions:

  • An accurate machine learning model, particularly XGBoost, can effectively predict the progression of pediatric SCAP to cSCAP.
  • PCT, LDH, RDW-CV, and BUN are significant indicators for early risk stratification of cSCAP in children.
  • The developed model offers valuable clinical support for healthcare providers in managing pediatric SCAP.

Related Concept Videos

Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
762
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
2.5K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.4K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
702
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
731